Abstract
Prior epidemiologic studies have shown that increasing body mass index (BMI) is associated with higher total cholesterol and low-density lipoprotein cholesterol (LDL). However, these studies were limited by underrepresentation of obese subjects. The aim of this study was to determine whether there is an association between BMI and lipid profiles in a population of patients with a broad spectrum of BMI values. A case-control study was performed involving patients seen at the Cleveland Clinic Florida. Cases (BMI >30 kg/m2) were obtained from the obesity surgery database between August 31, 2000, and April 4, 2002. Controls (BMI ≤ 30 kg/m2) were obtained from a database of primary care physicians between May 1, 2004, and November 18, 2004. Pearson correlation coefficients were used to assess the relationship between BMI and lipid fractions. Multiple linear regression was performed to assess the independent effect of BMI on lipid levels while adjusting for potential confounders and propensity scores. Six hundred thirty-seven patients were analyzed (females, n = 362, 57%). There was no association between higher BMI and LDL (r = 0.19 p = 0.07), a negative association with high-density lipoprotein cholesterol (HDL; r = 0.45, p < 0.001), and a positive association with the log transformation of triglycerides (r = 0.32, p = 0.005).
Higher BMI was inversely associated with HDL and directly associated with TG. BMI showed no significant association with LDL. Although the association between BMI and both HDL and TG may be explained by insulin resistance, the lack of a significant association between BMI and LDL remains an unexpected finding that requires further investigation.
Similar content being viewed by others
References
Krauss RM, Winston M, Fletcher BJ, et al. Obesity: impact on cardiovascular disease. Circulation. 1998;98:1472–6.
Després JP, Moorjani S, Tremblay A, et al. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein–lipid composition in premenopausal women. Clin Invest Med. 1989;12:374–80.
Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med. 1994;154:401–10.
Nicholls SJ, Tuzcu EM, Sipahi I, et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). Am J Cardiol. 2006;97:1553–7.
McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006;296:79–86.
Drapeau V, Lemieux I, Richard D, et al. Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg. 2006;16:501–9.
Anderson KM, Wilson PW, Garrison RJ, et al. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis. 1987;68:59–66.
Newman B, Selby JV, Quesenberry CP, et al. Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health. 1990;80:675–8.
Bertsias G, Mammas I, Linardakis M, et al. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003;3–3.
Kannel WB, Lebauer EJ, Dawber TR, et al. Relation of body weight to development of coronary heart disease: the Framingham Study. Circulation. 1967;35:734–44.
Howard BV, Knowler WC, Vasquez B, et al. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Comparison of diabetics and nondiabetics. Arteriosclerosis. 1984;4:462–71.
Uusitupa M, Siitonen O, Voutilainen E, et al. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diab Care. 1986;9:17–22.
Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body Weight, Cardiovascular risk factors, and coronary mortality. 15-Year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–9.
Reeder BA, Angel A, Ledoux M, et al. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group CMAJ. 1992;146:2009–19.
Rifkind BM, Begg T, Jackson ID. Relationship of plasma lipids and lipoproteins to obesity. Proc R Soc Med. 1966;59:1277–8.
Angel A. Pathophysiologic changes in obesity. CMAJ. 2005;23:421–9.
Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses arteriosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 1997;17:1082–90.
Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA Study. Obes Res. 2004;12:1914–20.
Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch of Int Med. 1993;153:1093–103.
Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773–81.
Onat A, Hergenc G, Sari I, et al. Elevated LDL-cholesterol level predicts diabetes in centrally obese women but not men: relative roles of insulin resistance and central obesity. Circ J. 2007;71:1463–7.
Hershcopf RJ, Elahi D, Andres R, et al. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chron Dis. 1982;35:101–14.
Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601–7.
Weinbrenner T, Schröder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr. 2006;83:30–5.
Dixon JB, O'Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord. 2001;25:793–7.
Vierhapper H, Nardi A, Grösser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607–10.
Rainwater DL, Mitchell BD, Comuzzie AG, Haffner SM. Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord. 1999;23:180–9.
Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39:1527–33.
Goff DC, D'Agostino RB, Haffner SM, et al. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism. 2005;54:264–70.
Saroja VV, Guowen C, Shelley CA, et al. Common set of genes regulates low-density lipoprotein size and obesity-related factors in Alaskan Eskimos: results from the GOCADAN study. Am J Hum Biol. 2006;18:525–31.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Author Disclosures
Dr. Samuel Szomstein is Consultant for Ethicon Endosurgery and for Covidien
Dr. Raul J Rosenthal is Ethicon Consultant and Educational Grant
Covidien Consultant and Educational Grant
Storz Consultant and Educational grant
Synovis Consultant and Educational
Rights and permissions
About this article
Cite this article
Shamai, L., Lurix, E., Shen, M. et al. Association of Body Mass Index and Lipid Profiles: Evaluation of a Broad Spectrum of Body Mass Index Patients Including the Morbidly Obese. OBES SURG 21, 42–47 (2011). https://doi.org/10.1007/s11695-010-0170-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-010-0170-7